Arbejdsmarkedets Tillaegspension Has $24.72 Million Stock Position in CME Group Inc. $CME

Arbejdsmarkedets Tillaegspension lowered its position in CME Group Inc. (NASDAQ:CME) by 2.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 83,708 shares of the financial services provider’s stock after selling 2,398 shares during the period. Arbejdsmarkedets Tillaegspension’s holdings in CME Group were worth $24,723,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in CME. Asset Dedication LLC increased its holdings in shares of CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares in the last quarter. Northwestern Mutual Investment Management Company LLC lifted its stake in shares of CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock valued at $3,147,000 after buying an additional 37 shares in the last quarter. Rehmann Capital Advisory Group lifted its stake in shares of CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after buying an additional 37 shares in the last quarter. Sovran Advisors LLC grew its holdings in shares of CME Group by 3.5% during the fourth quarter. Sovran Advisors LLC now owns 1,118 shares of the financial services provider’s stock valued at $305,000 after buying an additional 38 shares during the last quarter. Finally, Endowment Wealth Management Inc. grew its holdings in shares of CME Group by 4.4% during the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after buying an additional 38 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Transactions at CME Group

In other news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the transaction, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director William R. Shepard purchased 325 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The shares were acquired at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. The trade was a 0.12% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on CME shares. Jefferies Financial Group decreased their target price on shares of CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research report on Thursday, April 9th. Keefe, Bruyette & Woods raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price target on the stock in a research report on Thursday, June 18th. Morgan Stanley cut their price target on CME Group from $353.00 to $324.00 and set an “overweight” rating for the company in a research note on Friday. Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $316.00 to $323.00 in a report on Thursday, June 11th. Finally, Weiss Ratings downgraded CME Group from a “buy (b+)” rating to a “buy (b)” rating in a research note on Thursday, June 25th. Twelve investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $293.59.

CME Group Stock Up 2.0%

CME opened at $245.10 on Tuesday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company’s 50-day moving average is $261.81 and its 200 day moving average is $283.05. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The firm has a market capitalization of $88.81 billion, a P/E ratio of 20.91, a PEG ratio of 2.83 and a beta of 0.25.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping the consensus estimate of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.77 billion. During the same period in the previous year, the company earned $2.80 earnings per share. The firm’s revenue for the quarter was up 14.5% compared to the same quarter last year. Research analysts expect that CME Group Inc. will post 12.24 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date was Tuesday, June 9th. CME Group’s payout ratio is presently 44.37%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.